Skip to content

To study the effect of Lodhradi arka eye drops in allergic conjuctivitis.

An exploratory clinical trial to study efficacy of Lodhradi arka eye drops in simple allergic conjuctivitis. - Nil

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087327
Enrollment
55
Registered
2025-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

Intervention1: Lodhradi Arka Eye Drop: Misra S., Bhavaprakasa, Haritakyadi varga, vol- 1., Chaukhamba Publications, Reprint 2023, page no. 321 and 502 Control Intervention1: Nil: Nil

Sponsors

PDEAs college of ayurved and research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patient shows at least three signs and symptoms commonly seen in simple allergic conjunctivitis, listed below itching watering of eyes foreign body sensation photophobia hyperemia Patients aged between 18 and 50 years, regardless of gender, religion, or occupation.

Exclusion criteria

Exclusion criteria: Patient diagnosed with congenital eye abnormalities. Patient who has undergone ophthalmic surgery within the past month. Patient currently experiencing active eye infections. Patient having one eye.

Design outcomes

Primary

MeasureTime frame
To find efficacy of Lodhradi Arka Eye Drop in simple allergic conjunctivitisTimepoint: 15 days treatment with two followups on 8th and 15th day

Secondary

MeasureTime frame
To assess effect of Lodhradi Arka Eye Drop in simple allergic conjunctivitis to observe the adverse effect of drug if any.Timepoint: 15 days treatment with two followups on 8th and 15th day

Countries

India

Contacts

Public ContactDr Divya Shivaji Gardi

PDEAs college of ayurved and research centre

drvirkarchandana@gmail.com9822199107

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026